Atrys Health, S.A.
ATRY
Rank in Stocks
#16049
Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in... Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebranding to Atrys Health, S.A. in May 2016.
Share Price
$3.04
Last synced: 2026-11-11
Market Cap
$230.56M
Change (1 day)
3.30%
Change (1 year)
-9.68%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Atrys Health, S.A. (ATRY)
Category
Healthcare
EPS for Atrys Health, S.A. (ATRY)
EPS as of June 2026 TTM: $-1.43
According to Atrys Health, S.A.'s latest financial reports, its current EPS (TTM) is $-1.43. At the end of 2025 the company had an EPS of $-1.55, a decrease compared to its 2024 EPS of $-0.44.
EPS history for Atrys Health, S.A. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.43 | -7.91% |
| 2025 | $-1.55 | 254.39% |
| 2024 | $-0.44 | -34.12% |
| 2023 | $-0.66 | 81.88% |
| 2022 | $-0.36 | -25.42% |
| 2021 | $-0.49 | 100.74% |
| 2020 | $-0.24 | 4,329.09% |
| 2019 | $-0.01 | -885.71% |
| 2018 | 0.00 | -97.83% |
| 2017 | $0.03 | 411.11% |
| 2016 | $0.01 | -96.37% |
| 2015 | $0.17 | 263.39% |
| 2014 | $0.05 | -16.29% |
| 2013 | $0.06 | -48.47% |
| 2012 | $0.11 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,197.10% |
US
|
|
| $-7.07 | 395.31% |
US
|
|
| $-5.29 | 270.60% |
AU
|
|
| $12.88 | -1,002.35% |
BE
|
|
| $21.56 | -1,610.44% |
NL
|
Questions about Atrys Health, S.A.'s earnings per share (EPS)
What is Atrys Health, S.A.'s earnings per share (EPS)?
Atrys Health, S.A.'s earnings per share (EPS) over the last twelve months is $-1.43, as of Jun 2026.
What was Atrys Health, S.A.'s earnings per share (EPS) in 2025?
In 2025, Atrys Health, S.A.'s earnings per share (EPS) was $-1.55, compared with $-0.44 in 2024.
How has Atrys Health, S.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Atrys Health, S.A.'s earnings per share (EPS) was highest in 2020 ($-0.24) and lowest in 2025 ($-1.55).
How does Atrys Health, S.A.'s earnings per share (EPS) compare with similar companies?
Atrys Health, S.A.'s earnings per share (EPS) ($-1.43) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.